Browsing Institute Director's Office by Author "Emery, J"
Now showing items 1-9 of 9
-
The Chest Australia Trial: A Phase II Randomised Controlled Trial of an Intervention to Reduce Time to Consult with Symptoms of Lung Cancer
Emery, J; Murray, S; Campbell, N; Walter, FM; Mazza, D; Habgood, E; Kutzer, Y; Martin, A; Goodall, S; Barnes, D (2017-11) -
Dermoscopy for melanoma detection and triage in primary care: a systematic review
Jones, OT; Jurascheck, LC; van Melle, MA; Hickman, S; Burrows, NP; Hall, PN; Emery, J; Walter, FM (BMJ, 2019-08-20) -
Electronic clinical decision support tool for assessing stomach symptoms in primary care (ECASS): a feasibility study
Rubin, G; Walter, FM; Emery, J; Hamilton, W; Hoare, Z; Howse, J; Nixon, C; Srivastava, T; Thomas, C; Ukoumunne, OC (2021) -
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis
Druce, P; Calanzani, N; Snudden, C; Milley, K; Boscott, R; Behiyat, D; Martinez-Gutierrez, J; Saji, S; Oberoi, J; Funston, G (2021) -
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.
Druce, P; Calanzani, N; Snudden, C; Milley, K; Boscott, R; Behiyat, D; Martinez-Gutierrez, J; Saji, S; Oberoi, J; Funston, G (2021-06)INTRODUCTION: Lower gastrointestinal (GI) cancers are a major cause of cancer deaths worldwide. Prognosis improves with earlier diagnosis, and non-invasive biomarkers have the potential to aid with early detection. Substantial ... -
Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools
Funston, G; Hardy, V; Abel, G; Crosbie, EJ; Emery, J; Hamilton, W; Walter, FM (2020) -
MA22.06 Longer Lung Cancer Time Intervals Amongst Culturally and Linguistically Diverse Patient Than Anglo-Australian Patients
Mazza, D; Lin, X; Emery, J; Walter, F; Young, J; Barnes, D; Mitchell, P; Brijnath, B; Martin, A; O’Byrne, K (2019-10-01)Abstract MA22.06 -
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial.
Milton, S; McIntosh, J; Macrae, F; Chondros, P; Trevena, L; Jenkins, M; Walter, FM; Taylor, N; Boyd, L; Saya, S (BioMed Central, 2021-07-15)BACKGROUND: Australian guidelines recommend that all people aged 50-70 years old actively consider taking daily low-dose aspirin (100-300 mg per day) for 2.5 to 5 years to reduce their risk of colorectal cancer (CRC). ... -
Role of primary care physician factors on diagnostic testing and referral decisions for symptoms of possible cancer: a systematic review
Hardy, V; Yue, A; Archer, S; Merriel, SWD; Thompson, M; Emery, J; Usher-Smith, J; Walter, FM (2022)